Hasil Pencarian - Daniel Vis
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 3 hasil dari 3
-
1
-
2
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer oleh Sander A. L. Palit, Jeroen van Dorp, Daniel Vis, Cor Lieftink, Simon Linder, Roderick Beijersbergen, Andries M. Bergman, Wilbert Zwart, Michiel S. van der Heijden
Diterbitkan 2021-07-01
Artikel -
3
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth oleh Sander AL Palit, Daniel Vis, Suzan Stelloo, Cor Lieftink, Stefan Prekovic, Elise Bekers, Ingrid Hofland, Tonći Šuštić, Liesanne Wolters, Roderick Beijersbergen, Andries M Bergman, Balázs Győrffy, Lodewyk FA Wessels, Wilbert Zwart, Michiel S van der Heijden
Diterbitkan 2019-12-01
Artikel